Pim, UK
Living with MS since 2021
On Ocrevus since 2021
Pim, UK
Living with MS since 2021
On Ocrevus since 2021
You and your MS team have decided that you will receive your treatment with Ocrevus using an intravenous (IV) infusion (drip) procedure.1
Ocrevus will be given to you by a doctor or nurse who’s experienced in using this treatment, and they’ll monitor you closely throughout your infusion and for at least 1 hour afterwards. Your treatment will most likely take place in hospital.1
Ocrevus treatment begins with one dose split into two infusions separated by 2 weeks, with subsequent doses given as a single infusion.
You’ll need to spend up to 6 hours in hospital on each infusion day. While you’re having your infusion, you will be sitting up, so you can read, play games, watch films, listen to music or simply relax.
If you get a reaction during your infusion or within 24 hours (for example, itchy skin, a rash, a headache, or shortness of breath), tell your MS team straight away.1
If you miss an infusion of Ocrevus, talk to your MS team to arrange to have it as soon as possible. Don’t wait until your next planned infusion.1
Watch the video below to hear about what you might expect for your infusion
Pim
who has relapsing remitting MS (RRMS), on Ocrevus IV infusion
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. Please report suspected side effects to the MHRA through the Yellow Card scheme, via the Yellow card website www.mhra.gov.uk/yellowcard, or the free Yellow Card app available in the Apple App Store or Google Play Store. You should also report side effects to Roche Products Ltd. by emailing the Roche Drug Safety Centre at welwyn.uk_dsc@roche.com or calling +44 (0) 1707 367554. By reporting side effects you can help provide more information on the safety of this medicine.
References: